BOFAXA
DEAD

Serial Number

88791389

Owner

Teva Pharmaceuticals USA, Inc.

Filing Date

Feb 10, 2020

Add to watchlist:

No watchlists yet
View on USPTO

BOFAXA Trademark

Serial Number: 88791389

BOFAXA is a trademark filed by Teva Pharmaceuticals USA, Inc. on February 10, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Teva Pharmaceuticals USA, Inc. (585 trademarks)

650 Cathill Road
Sellersville, PA 18960

Entity Type: 03

Trademark Details

Filing Date

February 10, 2020

Registration Date

Not Registered

Published for Opposition

July 14, 2020

Goods & Services

Pharmaceutical preparations for the treatment of pain, cardiovascular diseases, respiratory diseases, central nervous system disorders, gastrointestinal diseases, and metabolic syndrome; Pharmaceutical preparations, namely, anti-viral agents, immunosuppressant agents, and corticosteroids; pharmaceutical preparations for use in oncology and endocrinology; pharmaceutical preparations for use in women's health, namely, for the treatment of breast cancer and post-menopausal symptoms; oral contraceptives

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 12, 2021 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 12, 2021 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 8, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 14, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jul 14, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 24, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 9, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 27, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 27, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 27, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 18, 2020 GNRN
NON-FINAL ACTION E-MAILED
Mar 18, 2020 GNRT
NON-FINAL ACTION WRITTEN
Mar 18, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 16, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 14, 2020 NWOS
NEW APPLICATION ENTERED
Feb 13, 2020 NWAP